期刊文献+

甲硫哒嗪对髓母细胞瘤DAOY细胞抑制作用研究

Study on thioridazine inhibiting the medulloblastoma cell line DAOY
下载PDF
导出
摘要 目的探讨神经安定类药物甲硫哒嗪(Thioridazine,THIO)对于髓母细胞瘤的抑制作用机制。方法利用人髓母细胞系DAOY和正常细胞系研究THIO最佳的给药浓度。利用CCK8、Transwell和定量PCR的方法研究THIO对DAOY细胞移动能力、生存能力及肿瘤干细胞特性基因表达的影响。结果 10μmol/L THIO可抑制DAOY细胞增殖及其在低糖条件下的生存能力,降低DAOY细胞移动,减少肿瘤干细胞特性基因的表达。结论 THIO对髓母细胞DAOY有抑制作用,为临床治疗髓母细胞瘤提供了理论依据。 Objective To study the mechanism of inhibition effect of thioridazine (THIO) on medulloblas- toma. Methods DAOY cell line and normal cell lines were used to study the optimal concentration of THIO. The effect of THIO on the migration and survival ability of DAOY and the cancer stem cell genes expression was investiga- ted by using CCK8, transwell and qPCR. Results 10 μmol/L THIO could inhibite the proliferation and the survival a- bility under starvation condition of DAOY,and reduce the cell migration and the expression of cancer stem cell genes. Conclusion THIO has antitumor effect on medulloblastoma cell line DAOY, which can provide further evidence to explore the effect of THIO in clinical treatment.
作者 邢丹 赵颖梅 刘志辉 张芳菲 李克冉 XING Dan;ZHAO Ying-mei;LIU Zhi-hui;ZHANG Fang-fei;LI Ke-ran(Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Co. ,Ltd. ,Shenyang 110000,China;Nanjing Third High School,Nanjing 210000,China)
出处 《实用药物与临床》 CAS 2018年第4期365-369,共5页 Practical Pharmacy and Clinical Remedies
关键词 髓母细胞瘤 甲硫哒嗪 肿瘤干细胞 Medulloblastoma Thioridazine Cancer stem cell
  • 相关文献

参考文献1

二级参考文献9

  • 1王玉东,艾志宏(综述),罗来敏(审校).保留生殖功能的子宫内膜癌治疗研究进展[J].国际肿瘤学杂志,2007,34(7):535-537. 被引量:4
  • 2Sachlos E, Risuano RM, Laronde S, et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells [J]. Cell,2012, 149(6) :1284-1297.
  • 3Kang S, Dong SM, Kim BR, et al. Thiofidazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells [ J ]. Apoptosis, 2012, 17 ( 9 ) : 989- 997.
  • 4Martin-Liberal J, Benson C, Messiou C, et al. Reversion of Hormone Treatment Resistance with the Addition of an roTOR Inhibitor in Endometrial Stromal Sarcoma [ J ]. Case Rep Med, 2014, 2014:612496.
  • 5Cben X, Zhang Z, Feng Y, et al. Aberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistance [J]. Mod Pathol, 2009, 22(5) :699-708.
  • 6Gu C, Zhang Z, Yu Y, et al. Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer [ J ]. Cancer Sci, 2011, 102(3) :557-564.
  • 7Shao R. Progesterone receptor isoforms A and B : new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma [ J ] , 2013, 18; 7:381.
  • 8Eaton JL, Unno K, Caraveo M, et al. Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endomctriosis [J]. J Clin Endocrinol Metab, 2013, 98 (12) : E1871-1879.
  • 9王晶,孙笑,王丽华,王玉东.PRB介导子宫内膜癌细胞对MPA敏感性的作用机制研究[J].中国药理学通报,2014,30(9):1252-1256. 被引量:3

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部